Investing in Japan
Latest UpdatesSuccess Story: Sun Pharma Japan Limited
Nov 08, 2017
Sun Pharmaceutical Industries Limited (SPIL), India’s largest and the world’s fourth largest pharmaceutical company in the generic drug industry, established its Japanese subsidiary, Sun Pharma Japan Limited (SP Japan), in Tokyo in March 2012. Mr. Kirti Ganorkar, Executive Vice President, SPIL, and Mr. Isao Muramatsu, Chairman of the Board of Directors of Japanese Subsidiary tell us about SPIL’s business strategies for the Japanese market, which is well-known especially for its very strict quality control in the world.
For more information about other cases, please see the Success Stories.